NO20054172L - New mixtures - Google Patents

New mixtures

Info

Publication number
NO20054172L
NO20054172L NO20054172A NO20054172A NO20054172L NO 20054172 L NO20054172 L NO 20054172L NO 20054172 A NO20054172 A NO 20054172A NO 20054172 A NO20054172 A NO 20054172A NO 20054172 L NO20054172 L NO 20054172L
Authority
NO
Norway
Prior art keywords
new mixtures
mixtures
new
formulations
fentanyl
Prior art date
Application number
NO20054172A
Other languages
Norwegian (no)
Other versions
NO20054172D0 (en
Inventor
Clive Booles
Calvin Ross
Alistair Campbell
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0305579.5A external-priority patent/GB0305579D0/en
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of NO20054172D0 publication Critical patent/NO20054172D0/en
Publication of NO20054172L publication Critical patent/NO20054172L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Abstract

Forehggende oppfinnelse angår formuleringer av fentanyl, spesielt pumpesprayformuleringer egnet for sublingval levering.The present invention relates to formulations of fentanyl, particularly pump spray formulations suitable for sublingual delivery.

NO20054172A 2003-03-11 2005-09-07 New mixtures NO20054172L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0305579.5A GB0305579D0 (en) 2003-03-11 2003-03-11 Pharmaceutical compositions
GB0328023A GB2399286A (en) 2003-03-11 2003-12-03 Sub-lingual fentanyl formulation
PCT/GB2004/001037 WO2004080382A2 (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl

Publications (2)

Publication Number Publication Date
NO20054172D0 NO20054172D0 (en) 2005-09-07
NO20054172L true NO20054172L (en) 2005-10-06

Family

ID=32992592

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054172A NO20054172L (en) 2003-03-11 2005-09-07 New mixtures

Country Status (10)

Country Link
EP (1) EP1608372A2 (en)
JP (1) JP2006519770A (en)
KR (1) KR20050115276A (en)
AU (1) AU2004218876B2 (en)
BR (1) BRPI0408209A (en)
CA (1) CA2516338A1 (en)
MX (1) MXPA05009602A (en)
NO (1) NO20054172L (en)
NZ (1) NZ541781A (en)
WO (1) WO2004080382A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2767163A1 (en) * 2005-02-17 2014-08-20 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals
GB0514043D0 (en) * 2005-07-08 2005-08-17 Arakis Ltd Fentanyl formulation
BRPI0707235B8 (en) * 2006-01-25 2021-05-25 Insys Therapeutics Inc sublingual fentanyl formulation without propellant, and, unit dose device for sublingual administration of a sublingual fentanyl formulation
DK2180844T3 (en) 2007-08-02 2018-04-23 Insys Dev Co Inc SUBLINGUAL FENTANYLSPRAY
GB2476494A (en) * 2009-12-24 2011-06-29 Norwich Pharma Technologies Ltd Formulation for the sublingual delivery of sufentanil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010389A1 (en) * 1994-09-30 1996-04-11 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmaceutical composition
EP1029536B1 (en) * 1997-10-01 2007-11-28 Novadel Pharma Inc. Buccal non-polar spray
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
SE9803239D0 (en) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
AU2879100A (en) * 1999-02-12 2000-08-29 Miles A. Libbey Iii Formulation and system for intra-oral delivery of pharmaceutical agents
WO2002011778A1 (en) * 2000-05-10 2002-02-14 University Of Kentucky Research Foundation System and method for intranasal administration of opioids
DE10064219B9 (en) * 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Novel pharmaceutical composition containing fentanyl and / or its derivatives

Also Published As

Publication number Publication date
WO2004080382A2 (en) 2004-09-23
NZ541781A (en) 2008-04-30
EP1608372A2 (en) 2005-12-28
BRPI0408209A (en) 2006-02-14
KR20050115276A (en) 2005-12-07
JP2006519770A (en) 2006-08-31
AU2004218876A1 (en) 2004-09-23
MXPA05009602A (en) 2005-11-08
NO20054172D0 (en) 2005-09-07
WO2004080382A3 (en) 2005-03-24
CA2516338A1 (en) 2004-09-23
AU2004218876B2 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
NO20060202L (en) Pyrrolodihydroisoquinolines as PDE-10 inhibitors
NO20090596L (en) Antiviral phosphinate compounds
DK1682530T3 (en) Pyrrole-substituted indoles as inhibitors of PAI-1
DK1881967T3 (en) Substituted benzo (D) isoaxol-3-yl-amine compounds as analgesics
SE0301372D0 (en) Novel compounds
NO20071078L (en) Antiviral compounds
NO20070866L (en) Antiviral compounds.
ATE433447T1 (en) PYRIMIIDINE COMPOUNDS
NO20045589L (en) New connections
NO20091976L (en) New connections
CY1110064T1 (en) FENYL-PIPERAZININE PRODUCTS AS SEROTONIN REFLECTION INHIBITORS
SE0202241D0 (en) Novel Compounds
BRPI1015043A2 (en) diazahomoadamantane derivatives and methods of use thereof
NO20055612L (en) Anti-inflammatory phosphonate compounds
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
ATE417849T1 (en) PYRAZOLOA4,3-DÜPYRIMIDINE
NO20055207L (en) Oral pharmaceutical preparation for proton pump antagonists
NO20055396D0 (en) New phosphonic acid compounds as erin protease inhibitors
NO20054172L (en) New mixtures
NO20063293L (en) Pharmaceutical compounds
ATE430148T1 (en) NEW PYRROLODIHYDROISOCHINOLINES AS PDE10 INHIBITORS
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
DK1583756T3 (en) Thiophene carboxamides as inhibitors of the enzyme IKK-2
EA200801549A1 (en) NEW PENANTRIDINE DERIVATIVES AS ANTAGONISTS OF BRADIKININ
AP1543A (en) Phenyl heterocyclyl ethers.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application